Imedex® is an industry leader in providing certified, independent continuing medical education to health care professionals.
Continuing Medical Education
Imedex®, LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
This activity has been approved for AMA PRA Category 1 Credit™.
Maintenance of Certification
Successful completion of this CME activity enables a participant to earn MOC points [and patient safety credit] towards the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is Imedex’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC Points.
Who Should Attend
This educational activity is specifically designed for gastroenterologists, hospitalists, internal medicine specialists, and other healthcare professionals (physicians-in-training, nurses, pharmacists, physicians assistants, etc.) involved and/or interested in the therapeutic management of patients with IBD.
After successful completion of this activity, participants should be able to:
- Identify optimal treatment strategies for IBD, including Crohn's disease and ulcerative colitis
- Interpret the latest data and challenges from ongoing clinical trials focused on targeted-therapy for IBD
- Evaluate and select evidence-based treatment regimens that may improve patient outcomes and quality of care
- Identify controversies that impact therapeutic algorithms to mitigate risks of therapy and allow integration of promising therapeutic options